Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Stock Forecast

Stock Price Forecast

The 9 analysts that cover Adaptive Biotechnologies stock have a consensus rating of "Strong Buy" and an average price target of $17.78, which forecasts a 10.85% increase in the stock price over the next year. The lowest target is $10 and the highest is $22.

Price Target: $17.78 (+10.85%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$17.78	$20	$22
Change	-37.66%	+10.85%	+24.69%	+37.16%

Analyst Ratings

The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	5	5	5	5	5	5
Buy	3	4	4	4	4	3
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	10	10	10	10	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sebastian Sandler JP Morgan	JP Morgan	Buy Maintains $20 → $21	Buy	Maintains	$20 → $21	+30.92%	Feb 6, 2026
Mark Massaro BTIG	BTIG	Strong Buy Maintains $21 → $22	Strong Buy	Maintains	$21 → $22	+37.16%	Feb 6, 2026
Subbu Nambi Guggenheim	Guggenheim	Strong Buy Maintains $20 → $21	Strong Buy	Maintains	$20 → $21	+30.92%	Jan 26, 2026
Tejas Savant Morgan Stanley	Morgan Stanley	Hold Maintains $11 → $16	Hold	Maintains	$11 → $16	-0.25%	Nov 11, 2025
Mark Massaro BTIG	BTIG	Strong Buy Maintains $19 → $21	Strong Buy	Maintains	$19 → $21	+30.92%	Nov 6, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

271.41M

Decreased by -2.01%

from 276.98M

Revenue Next Year

333.96M

Increased by 23.05%

from 271.41M

EPS This Year

-0.60

from -0.39

EPS Next Year

-0.38

from -0.60

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	154.34M	185.31M	170.28M	178.96M	276.98M	271.41M	333.96M
Revenue Growth	56.88%	20.06%	-8.11%	5.10%	54.77%	-2.01%	23.05%
EPS	-1.48	-1.40	-1.56	-1.08	-0.39	-0.60	-0.38
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	9

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	285.6M	369.2M
Avg	271.4M	334.0M
Low	250.6M	307.6M

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	3.1%	36.0%
Avg	-2.0%	23.0%
Low	-9.5%	13.3%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-0.54	-0.30
Avg	-0.60	-0.38
Low	-0.64	-0.46

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.